文献速递肝胆胰外科

增强现实联合吲哚菁绿荧光成像引导腹腔镜肝段切除术治疗肝细胞癌的疗效

Efficacy of Augmented Reality Combined with Indocyanine Green Fluorescence Imaging Guided Laparoscopic Segmentectomy for Hepatocellular Carcinoma.
PubMed 文献 · J Am Coll Surg · 2023-11-22

回顾性分析98例肝细胞癌患者,分为ARN-FI组45例和非ARN-FI组53例,比较腹腔镜解剖性肝段切除术的术中术后结果。ARN-FI组术中出血量(100 vs 200 mL,p=0.005)和残留肝缺血发生率(13.3% vs 30.2%,p=0.046)更低,1年和3年无病生存率均更高(91.01% vs 71.15%和70.01% vs 52.46%,p=0.047)。结论认为ARN-FI技术安全可行,具有良好临床应用前景。

要点

  • ARN-FI组术中出血量100 mL,低于非ARN-FI组的200 mL(p=0.005)。
  • ARN-FI组残留肝缺血发生率13.3%,低于非ARN-FI组的30.2%(p=0.046)。
  • ARN-FI组1年和3年无病生存率分别为91.01%和70.01%,均高于非ARN-FI组的71.15%和52.46%(p=0.047)。

核心结论

  • ARN-FI技术为腹腔镜肝切除术中的肝实质离断提供更规范的方法,有效减少术中出血、降低术后残留肝缺血并改善肿瘤学预后,该方法安全可行且具有良好的临床应用前景。

研究设计与样本

  • 回顾性分析2018年1月至2022年1月诊断为肝细胞癌并接受腹腔镜解剖性肝段切除术的98例患者,根据术中是否应用ARN联合FI分为ARN-FI组(45例)和非ARN-FI组(53例),比较术中及术后结果。

主要发现

  • 两组术前基线数据和术后并发症发生率无显著差异。
  • ARN-FI组术中出血量为100 mL,非ARN-FI组为200 mL(p=0.005)。
  • ARN-FI组残留肝缺血发生率为13.3%,非ARN-FI组为30.2%(p=0.046)。
  • ARN-FI组和非ARN-FI组的1年无病生存率分别为91.01%和71.15%,3年无病生存率分别为70.01%和52.46%,组间差异有统计学意义(p=0.047)。

临床怎么用

  • 原文结论认为ARN-FI技术为腹腔镜肝切除术中肝实质离断提供更规范的方法,安全可行且具有良好临床应用前景。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The internal anatomy of the liver is extremely complex. Laparoscopic anatomical segmentectomy requires reference to the position and alignment of intrahepatic vascular. However, the surface of the liver lacks anatomical landmarks and the liver segment boundaries cannot be identified with the naked eye. Augmented reality navigation (ARN) and indocyanine green fluorescence imaging (FI) are emerging navigation tools in liver resection. This study aimed to explore the efficacy and application value of laparoscopic anatomical segmentectomy guided by ARN combined with indocyanine green FI. STUDY DESIGN: Ninety-eight patients who were diagnosed with hepatocellular carcinoma and underwent laparoscopic anatomical segmentectomy from January 2018 to January 2022 were retrospectively analyzed. They were divided into the ARN-FI group (45 patients) and the non-ARN-FI group (53 patients) based on whether ARN combined with FI was applied during the operation. The differences in intraoperative and postoperative outcomes were compared. RESULTS: There was no significant difference in preoperative baseline data and postoperative complication rates between the 2 groups. Compared with the non-ARN-FI group, the ARN-FI group had much lower intraoperative blood loss (100 vs 200 mL, p = 0.005) and a lower incidence of remnant liver ischemia (13.3% vs 30.2%, p = 0.046). The 1- and 3-year disease-free survival rates in the ARN-FI and non-ARN-FI groups were 91.01% vs 71.15% and 70.01% vs 52.46%, respectively; the differences between the 2 groups were statistically significant (p = 0.047). CONCLUSIONS: The ARN-FI technology provides a more standardized approach for liver parenchyma section during laparoscopic liver resection, effectively minimizing intraoperative blood loss, reducing postoperative remnant liver ischemia, and improving oncological prognosis. This method is safe and feasible and has good clinical application prospects.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Wang D, Hu H, Zhang Y, et al. Efficacy of Augmented Reality Combined with Indocyanine Green Fluorescence Imaging Guided Laparoscopic Segmentectomy for Hepatocellular Carcinoma. J Am Coll Surg. 2023. PMID: 37991244. doi:10.1097/XCS.0000000000000912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。